{"id":37111,"date":"2026-06-26T05:53:46","date_gmt":"2026-06-26T00:23:46","guid":{"rendered":"https:\/\/atsixty.com\/?p=37111"},"modified":"2026-06-26T05:54:21","modified_gmt":"2026-06-26T00:24:21","slug":"endometriosis-adenomyosis","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/","title":{"rendered":"Endometriosis & Adenomyosis"},"content":{"rendered":"\n\n\n\n\nMorning Rounds \u00b7 Endometriosis & Adenomyosis<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#gyn04 *,#gyn04 *::before,#gyn04 *::after{box-sizing:border-box;margin:0;padding:0}\n#gyn04{\n --ob:#4B3A6E;\n --ob-light:#5F4D85;\n --ob-pale:#EFE9F5;\n --ob-dark:#362952;\n --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n --ink:#241B36;--ink-mid:#4A3D63;--ink-soft:#8A7FA0;\n --line:#E0D8EC;--cream:#F8F6FB;--warm:#FCFBFD;\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;color:var(--ink);background:var(--cream);\n line-height:1.7;padding:0 0 64px;\n}\n#gyn04 .mr-header{background:var(--ob);color:#F3EFFA;padding:34px 24px 28px;text-align:center}\n#gyn04 .mr-eyebrow{font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;font-weight:600;opacity:0.65;margin-bottom:10px}\n#gyn04 .mr-title{font-family:'Playfair Display',serif;font-size:1.75rem;font-weight:700;line-height:1.2;margin-bottom:4px}\n#gyn04 .mr-title em{font-style:italic;font-weight:400;opacity:0.88}\n#gyn04 .mr-subtitle{font-size:0.82rem;opacity:0.7;margin-top:8px;font-style:italic}\n#gyn04 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap}\n#gyn04 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.73rem}\n#gyn04 .mr-sentinel{height:1px}\n#gyn04 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(36,27,54,0.08);padding:9px 16px;display:none}\n#gyn04 .mr-progress.visible{display:block}\n#gyn04 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#gyn04 .mr-pips{display:flex;align-items:center;justify-content:center}\n#gyn04 .mr-pip-wrap{display:flex;align-items:center}\n#gyn04 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#gyn04 .mr-pip-line.done{background:var(--ob)}\n#gyn04 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0}\n#gyn04 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn04 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn04 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#gyn04 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ob);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 6px rgba(36,27,54,0.05)}\n#gyn04 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#gyn04 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ob);opacity:0.16;line-height:1;margin-top:-2px;flex-shrink:0}\n#gyn04 .mr-meta{flex:1}\n#gyn04 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob);opacity:0.75;margin-bottom:5px}\n#gyn04 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#gyn04 .mr-stem strong{font-weight:600}\n#gyn04 .mr-stem em{font-style:italic}\n#gyn04 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#gyn04 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#gyn04 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent}\n#gyn04 .mr-opt:hover{border-color:var(--ob);background:var(--ob-pale)}\n#gyn04 .mr-opt.locked{cursor:default}\n#gyn04 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#gyn04 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#gyn04 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#gyn04 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#gyn04 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#gyn04 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#gyn04 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#gyn04 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s}\n#gyn04 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn04 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn04 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#gyn04 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#gyn04 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#gyn04 .mr-exp{display:none;border-top:1px solid #d4c5e8;background:linear-gradient(180deg,#ece4f6 0%,#f4eff9 100%);padding:13px 20px 15px}\n#gyn04 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:#3F2D60;margin-bottom:6px}\n#gyn04 .mr-exp-text{font-size:0.86rem;color:#2A1F40;line-height:1.68}\n#gyn04 .mr-exp-text strong{font-weight:600}\n#gyn04 .mr-exp-text em{font-style:italic}\n#gyn04 .mr-img-wrap{margin-top:14px;background:var(--warm);border:1px solid var(--line);border-radius:8px;padding:14px;text-align:center}\n#gyn04 .mr-img-wrap figcaption{font-size:0.73rem;color:var(--ink-soft);font-style:italic;margin-top:8px;line-height:1.4}\n#gyn04 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#gyn04 .mr-btn{background:var(--ob);color:#F3EFFA;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 8px rgba(75,58,110,0.28)}\n#gyn04 .mr-btn:hover{background:var(--ob-dark)}\n#gyn04 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ob);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(36,27,54,0.08);overflow:hidden}\n#gyn04 .mr-score-in{padding:28px 24px;text-align:center}\n#gyn04 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600}\n#gyn04 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ob) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative}\n#gyn04 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm)}\n#gyn04 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#gyn04 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ob)}\n#gyn04 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#gyn04 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#gyn04 .mr-score-net{font-size:0.9rem;color:var(--ob);font-weight:600;margin-bottom:4px}\n#gyn04 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#gyn04 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#gyn04 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#gyn04 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#gyn04 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#gyn04 .mr-band-s{background:var(--ob-pale);color:var(--ob)}\n#gyn04 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ob);color:var(--ob);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer}\n#gyn04 .mr-retry:hover{background:var(--ob);color:#F3EFFA}\n@media(max-width:480px){#gyn04 .mr-title{font-size:1.4rem}#gyn04 .mr-num{font-size:1.7rem}#gyn04 .mr-stem{font-size:0.9rem}#gyn04 .mr-opt-text{font-size:0.86rem}}\n<\/style>\n\n<div id=\"gyn04\">\n\n <div class=\"mr-header\">\n <div class=\"mr-eyebrow\">Morning Rounds · Gynaecology Series · Round 04<\/div>\n <div class=\"mr-title\">\n Endometriosis &<br><em>Adenomyosis<\/em>\n <\/div>\n <div class=\"mr-subtitle\">Five cases · Diagnosis, pathophysiology, infertility & long-term management · Trust your instinct<\/div>\n <div class=\"mr-chips\">\n <span class=\"mr-chip\">5 Cases<\/span>\n <span class=\"mr-chip\">+4 \/ −1 scoring<\/span>\n <span class=\"mr-chip\">Options reshuffled<\/span>\n <\/div>\n <\/div>\n\n <div class=\"mr-sentinel\" id=\"gyn04-sentinel\"><\/div>\n\n <div class=\"mr-progress\" id=\"gyn04-progress\">\n <div class=\"mr-prog-inner\">\n <div class=\"mr-pips\" id=\"gyn04-pips\"><\/div>\n <\/div>\n <\/div>\n\n <div class=\"mr-body\">\n <div id=\"gyn04-cases\"><\/div>\n <div class=\"mr-submit-wrap\">\n <button class=\"mr-btn\" id=\"gyn04-submit\">Submit for Debrief<\/button>\n <\/div>\n <div class=\"mr-score\" id=\"gyn04-score\">\n <div class=\"mr-score-in\">\n <div class=\"mr-score-ey\">Round Complete<\/div>\n <div class=\"mr-ring\" id=\"gyn04-ring\">\n <div class=\"mr-ring-in\">\n <span class=\"mr-ring-pct\" id=\"gyn04-pct\">0%<\/span>\n <span class=\"mr-ring-sub\">net<\/span>\n <\/div>\n <\/div>\n <div class=\"mr-score-title\">Your Debrief<\/div>\n <div class=\"mr-score-net\" id=\"gyn04-net\"><\/div>\n <div class=\"mr-verdict\" id=\"gyn04-verdict\"><\/div>\n <div class=\"mr-bands\">\n <span class=\"mr-band mr-band-c\" id=\"gyn04-ct-c\"><\/span>\n <span class=\"mr-band mr-band-w\" id=\"gyn04-ct-w\"><\/span>\n <span class=\"mr-band mr-band-s\" id=\"gyn04-ct-s\"><\/span>\n <\/div>\n <button class=\"mr-retry\" id=\"gyn04-retry\">↻ New Round<\/button>\n <\/div>\n <\/div>\n <\/div>\n\n<\/div><!-- end #gyn04 -->\n\n<script>\n(function () {\n 'use strict';\n\n var NS = 'gyn04';\n var TOTAL = 5;\n var MAX = 20;\n var LTRS = ['A','B','C','D'];\n\n var QS = [\n\n {\n id: 1,\n tag: 'Endometriosis — Diagnosis',\n stem: 'A 28-year-old reports progressively worsening dysmenorrhea, deep dyspareunia, and difficulty conceiving for 18 months. Transvaginal ultrasound shows a 4 cm endometrioma on one ovary but no other findings. What is required to definitively diagnose endometriosis, and does the ultrasound finding alone suffice?',\n correct: 'Ultrasound can suggest an endometrioma and support a clinical diagnosis, but the definitive diagnosis of endometriosis is made by laparoscopic visualisation with biopsy and histological confirmation, particularly for peritoneal or superficial implants, since imaging alone cannot confirm or stage all disease present',\n opts: [\n 'Ultrasound can suggest an endometrioma and support a clinical diagnosis, but the definitive diagnosis of endometriosis is made by laparoscopic visualisation with biopsy and histological confirmation, particularly for peritoneal or superficial implants, since imaging alone cannot confirm or stage all disease present',\n 'The ultrasound finding of an endometrioma is itself sufficient and definitive confirmation of endometriosis, since this specific imaging appearance is considered pathognomonic and does not require any further procedure for diagnostic confirmation to be made',\n 'A definitive diagnosis requires elevated serum CA-125 levels in addition to the ultrasound finding, since CA-125 is considered a required diagnostic biomarker for confirming endometriosis prior to any surgical intervention being planned or pursued',\n 'Since symptoms alone (dysmenorrhea, dyspareunia, infertility) are highly specific for endometriosis in this age group, a clinical diagnosis can be made on history alone without imaging or laparoscopy, and management can proceed directly on that basis'\n ],\n exp: 'An <strong>endometrioma on ultrasound<\/strong> is highly suggestive of that specific lesion and supports a clinical diagnosis, but <strong>laparoscopy with histological confirmation<\/strong> remains the definitive diagnostic standard — especially since peritoneal and superficial implants, which carry their own diagnostic and prognostic weight, are simply not visible on ultrasound. <br><br>Treating the endometrioma appearance as <strong>pathognomonic<\/strong> overstates what imaging alone can confirm. <strong>CA-125<\/strong> can be elevated in endometriosis but is non-specific (also raised in fibroids, PID, and malignancy) and is not a required diagnostic biomarker. And while symptoms are characteristic, <strong>history alone<\/strong> does not constitute a definitive diagnosis — the same symptom triad overlaps with several other pelvic pain conditions.',\n imgId: null\n },\n\n {\n id: 2,\n tag: 'Adenomyosis vs Leiomyoma — Distinguishing Features',\n stem: 'A 42-year-old has heavy, painful periods that have progressively worsened over several years. Bimanual exam reveals a diffusely enlarged, globular, tender uterus without discrete masses. What does this clinical picture suggest compared to a uterus with multiple fibroids, and what would imaging typically show?',\n correct: 'This is more consistent with adenomyosis than leiomyoma — a diffusely enlarged, symmetrically globular, tender uterus without discrete masses, worsening over years; MRI typically shows a thickened, ill-defined junctional zone, whereas fibroids present as well-circumscribed masses with irregular, not symmetric, enlargement',\n opts: [\n 'This is more consistent with adenomyosis than leiomyoma — a diffusely enlarged, symmetrically globular, tender uterus without discrete masses, worsening over years; MRI typically shows a thickened, ill-defined junctional zone, whereas fibroids present as well-circumscribed masses with irregular, not symmetric, enlargement',\n 'This picture is more consistent with leiomyoma than adenomyosis, since diffuse uterine enlargement without discrete masses is the classic presentation of multiple small intramural fibroids that have not yet become individually palpable on bimanual examination',\n 'A diffusely enlarged, tender uterus without discrete masses is equally consistent with either adenomyosis or leiomyoma, since neither condition has clinical or imaging features that reliably distinguish one from the other on routine assessment in practice',\n 'This presentation specifically suggests leiomyoma with secondary degeneration, since fibroid degeneration characteristically produces a diffusely tender uterus with loss of the discrete mass effect typically seen in non-degenerated fibroids on examination'\n ],\n exp: '<strong>Adenomyosis<\/strong> classically produces a symmetrically enlarged, globular, \"boggy,\" tender uterus — ectopic endometrial glands within the myometrium — with progressively worsening dysmenorrhea typically in the late thirties to forties. MRI shows a <strong>thickened, ill-defined junctional zone<\/strong>. <strong>Fibroids<\/strong>, by contrast, cause irregular (not symmetric) enlargement with discrete, well-circumscribed masses on imaging. <br><br>Diffuse enlargement without discrete masses is the opposite of the typical <strong>fibroid<\/strong> picture, not a subtle variant of it. The two conditions <strong>are<\/strong> reliably distinguishable on MRI in the large majority of cases, so treating them as indistinguishable overstates real diagnostic uncertainty. And fibroid <strong>degeneration<\/strong> typically presents acutely (sudden pain over a degenerating mass) rather than as a years-long progressive pattern, so it doesn\\'t fit this history.',\n imgId: null\n },\n\n {\n id: 3,\n tag: 'Endometriosis — Stage-Symptom Correlation',\n stem: 'A patient with laparoscopically confirmed minimal endometriosis (ASRM stage I, a few small superficial implants) reports severe, debilitating pelvic pain, while another patient with extensive stage IV disease (large endometriomas, dense adhesions) reports only mild discomfort. How should this discordance be interpreted?',\n correct: 'This is a well-recognised feature of endometriosis — the anatomical stage correlates poorly with pain severity, likely because pain relates more to lesion depth, inflammatory mediator activity, and nerve involvement than to total visible disease burden, so staging should not be used to predict or dismiss pain',\n opts: [\n 'This is a well-recognised feature of endometriosis — the anatomical stage correlates poorly with pain severity, likely because pain relates more to lesion depth, inflammatory mediator activity, and nerve involvement than to total visible disease burden, so staging should not be used to predict or dismiss pain',\n 'This discordance is unusual and suggests a diagnostic error in one of the two cases, since pain severity in endometriosis should otherwise correlate directly and proportionally with the anatomical extent and stage of disease visualised at laparoscopy',\n 'The patient with minimal disease should be evaluated for an alternative cause of pelvic pain entirely, since stage I endometriosis with only a few small implants is not considered capable of producing debilitating pain by itself in standard clinical experience',\n 'The discordance reflects a difference in pain tolerance between the two patients rather than any disease-related factor, since the biological basis for endometriosis-related pain is otherwise expected to scale consistently with the volume of visible disease'\n ],\n exp: 'It is well established that <strong>ASRM staging<\/strong> (based on extent, depth, and location of implants\/adhesions) correlates poorly with pain severity. <strong>Deep infiltrating lesions<\/strong> on the uterosacral ligaments or rectovaginal septum, or implants with greater nerve fibre involvement and local inflammatory mediator activity, can cause severe pain from a small visible burden — while extensive disease can sometimes be relatively painless. <br><br>This is not a <strong>diagnostic error<\/strong> — it is consistent, reproducible disease biology, not an anomaly requiring re-evaluation. Minimal disease is fully <strong>capable<\/strong> of producing severe pain, so redirecting to an alternative diagnosis on stage alone is premature. And reducing the discordance to <strong>pain tolerance<\/strong> dismisses a real organic mechanism rather than explaining it.',\n imgId: null\n },\n\n {\n id: 4,\n tag: 'Endometriosis-Associated Infertility — Mechanism',\n stem: 'A 30-year-old with laparoscopically confirmed minimal endometriosis (a few small peritoneal implants, no adhesions, normal tubal patency) has been unable to conceive for 14 months. Since there is no mechanical tubal blockage or anatomical distortion, what is the most likely mechanism contributing to her infertility?',\n correct: 'In minimal to mild endometriosis without mechanical distortion, infertility is thought to result from an altered peritoneal environment — inflammatory mediators and prostaglandins from ectopic implants impair oocyte quality, fertilisation, and implantation, rather than anatomical blockage, more relevant only in moderate-to-severe disease',\n opts: [\n 'In minimal to mild endometriosis without mechanical distortion, infertility is thought to result from an altered peritoneal environment — inflammatory mediators and prostaglandins from ectopic implants impair oocyte quality, fertilisation, and implantation, rather than anatomical blockage, more relevant only in moderate-to-severe disease',\n 'Without mechanical tubal blockage or anatomical distortion present on laparoscopy, endometriosis itself cannot meaningfully account for her infertility, and an entirely separate cause should be sought rather than attributing her difficulty conceiving to the diagnosed minimal disease present',\n 'Infertility in this scenario is most likely due to endometriosis-associated premature ovarian insufficiency, since the peritoneal implants are understood to directly accelerate follicular depletion regardless of the limited extent of disease present here currently',\n 'The mechanism here is the same mechanical distortion seen in more advanced disease — even a few small implants are considered sufficient, on their own, to physically obstruct normal oocyte pickup by the fimbria despite a laparoscopically confirmed normal tubal architecture'\n ],\n exp: 'In <strong>minimal-to-mild disease<\/strong> without adhesions or distorted anatomy, the dominant mechanism is biochemical rather than mechanical — an altered peritoneal fluid environment with raised <strong>inflammatory cytokines and prostaglandins<\/strong> impairs oocyte quality, sperm function, fertilisation, and implantation. <strong>Mechanical distortion<\/strong> (adhesions, tubal blockage, ovarian fixation) becomes the dominant mechanism only in more advanced disease. <br><br>Dismissing minimal disease as incapable of causing infertility ignores this well-established inflammatory pathway. <strong>Premature ovarian insufficiency<\/strong> and implants <strong>physically obstructing the fimbria<\/strong> are not recognised mechanisms of minimal-disease infertility — both invent a mechanical or follicular explanation where the evidence instead points to an inflammatory one.',\n imgId: null\n },\n\n {\n id: 5,\n tag: 'Endometriosis Management & GnRH Agonist Risk',\n stem: 'A woman with endometriosis-related pelvic pain, not currently desiring pregnancy, is started on a GnRH agonist for long-term symptom suppression. What specific risk does this therapy carry, and what does management need to address alongside it?',\n correct: 'GnRH agonists induce a hypoestrogenic state that, if continued long-term, carries a risk of accelerated bone mineral density loss; management should include \"add-back\" therapy (low-dose oestrogen-progestin) to mitigate this, with duration typically limited unless add-back is used',\n opts: [\n 'GnRH agonists induce a hypoestrogenic state that, if continued long-term, carries a risk of accelerated bone mineral density loss; management should include \"add-back\" therapy (low-dose oestrogen-progestin) to mitigate this, with duration typically limited unless add-back is used',\n 'GnRH agonist therapy carries a risk of significant weight gain and fluid retention as its primary long-term concern, and management should focus on dietary counselling and diuretic use rather than any hormonal add-back strategy during treatment',\n 'The main long-term risk of GnRH agonist therapy is endometrial hyperplasia from sustained oestrogen stimulation, and management should address this by adding a progestin-only method specifically to prevent endometrial proliferation during treatment',\n 'GnRH agonists can be continued indefinitely at full dose without specific long-term risk once pain control is achieved, since suppression of ovarian hormone production is not associated with any clinically significant skeletal or metabolic consequence over time'\n ],\n exp: 'GnRH agonists downregulate pituitary receptors, suppressing FSH\/LH and inducing a <strong>hypoestrogenic, menopause-like state<\/strong> — effective for symptom control but carrying a real risk of <strong>accelerated bone mineral density loss<\/strong> if sustained. <strong>\"Add-back\" therapy<\/strong> (low-dose oestrogen-progestin, or tibolone) preserves therapeutic suppression while protecting bone, and is what allows longer treatment durations beyond the otherwise limited window. <br><br>Weight gain\/fluid retention is not the defining long-term risk here. <strong>Endometrial hyperplasia<\/strong> inverts the actual hormonal state — this therapy causes hypo-, not hyperoestrogenism, so proliferation risk is not the concern. And \"no significant long-term risk\" ignores the well-documented <strong>osteoporosis risk<\/strong> that is the entire reason add-back therapy and duration limits exist.',\n imgId: null\n }\n\n ];\n\n var answers = {};\n var answered = 0;\n var shuffled = {};\n var done = false;\n\n function byId(id) { return document.getElementById(id); }\n function gid(suffix) { return byId(NS + '-' + suffix); }\n\n function shuffleArr(arr) {\n var a = arr.slice(), i, j, tmp;\n for (i = a.length - 1; i > 0; i--) {\n j = Math.floor(Math.random() * (i + 1));\n tmp = a[i]; a[i] = a[j]; a[j] = tmp;\n }\n return a;\n }\n\n function countVal(val) {\n var k, n = 0;\n for (k in answers) {\n if (answers.hasOwnProperty(k) && answers[k] === val) n++;\n }\n return n;\n }\n\n function buildPips() {\n var cont = gid('pips'), i, q, wLine, wPip, line, pip;\n cont.innerHTML = '';\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n if (i > 0) {\n wLine = document.createElement('div');\n wLine.className = 'mr-pip-wrap';\n line = document.createElement('div');\n line.className = 'mr-pip-line';\n line.id = NS + '-pl' + q.id;\n wLine.appendChild(line);\n cont.appendChild(wLine);\n }\n wPip = document.createElement('div');\n wPip.className = 'mr-pip-wrap';\n pip = document.createElement('div');\n pip.className = 'mr-pip';\n pip.id = NS + '-pip' + q.id;\n pip.textContent = String(q.id);\n wPip.appendChild(pip);\n cont.appendChild(wPip);\n }\n }\n\n function build() {\n var cont, i, q, opts, card, top, numDiv, meta, tag, stem,\n rule, optsDiv, expDiv, lbl, txt, imgDiv, imgSrc, j,\n optEl, ltrSpan, txtSpan;\n\n cont = gid('cases');\n cont.innerHTML = '';\n answers = {}; answered = 0; shuffled = {}; done = false;\n gid('score').style.display = 'none';\n buildPips();\n\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n opts = shuffleArr(q.opts);\n shuffled[q.id] = opts;\n\n card = document.createElement('div');\n card.className = 'mr-case';\n\n top = document.createElement('div');\n top.className = 'mr-case-top';\n\n numDiv = document.createElement('div');\n numDiv.className = 'mr-num';\n numDiv.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n meta = document.createElement('div');\n meta.className = 'mr-meta';\n\n tag = document.createElement('div');\n tag.className = 'mr-tag';\n tag.innerHTML = q.tag;\n\n stem = document.createElement('div');\n stem.className = 'mr-stem';\n stem.innerHTML = q.stem;\n\n meta.appendChild(tag);\n meta.appendChild(stem);\n top.appendChild(numDiv);\n top.appendChild(meta);\n card.appendChild(top);\n\n rule = document.createElement('div');\n rule.className = 'mr-rule';\n card.appendChild(rule);\n\n optsDiv = document.createElement('div');\n optsDiv.className = 'mr-opts';\n\n for (j = 0; j < opts.length; j++) {\n optEl = document.createElement('div');\n optEl.className = 'mr-opt';\n optEl.id = NS + '-o' + q.id + '-' + j;\n optEl.setAttribute('role', 'button');\n optEl.setAttribute('tabindex', '0');\n\n ltrSpan = document.createElement('span');\n ltrSpan.className = 'mr-ltr';\n ltrSpan.textContent = LTRS[j];\n\n txtSpan = document.createElement('span');\n txtSpan.className = 'mr-opt-text';\n txtSpan.innerHTML = opts[j];\n\n optEl.appendChild(ltrSpan);\n optEl.appendChild(txtSpan);\n optsDiv.appendChild(optEl);\n\n (function (qid, oi) {\n optEl.addEventListener('click', function () { pick(qid, oi); });\n }(q.id, j));\n }\n card.appendChild(optsDiv);\n\n expDiv = document.createElement('div');\n expDiv.className = 'mr-exp';\n expDiv.id = NS + '-exp' + q.id;\n\n lbl = document.createElement('div');\n lbl.className = 'mr-exp-lbl';\n lbl.textContent = 'Debrief';\n\n txt = document.createElement('div');\n txt.className = 'mr-exp-text';\n txt.innerHTML = q.exp;\n\n expDiv.appendChild(lbl);\n expDiv.appendChild(txt);\n\n if (q.imgId) {\n imgSrc = byId(q.imgId);\n if (imgSrc) {\n imgDiv = document.createElement('div');\n imgDiv.innerHTML = imgSrc.innerHTML;\n expDiv.appendChild(imgDiv);\n }\n }\n\n card.appendChild(expDiv);\n cont.appendChild(card);\n }\n }\n\n function pick(qid, oi) {\n var q, opts, i, el, correct;\n if (answers[qid] !== undefined || done) return;\n\n q = null;\n for (i = 0; i < QS.length; i++) {\n if (QS[i].id === qid) { q = QS[i]; break; }\n }\n if (!q) return;\n\n opts = shuffled[qid];\n correct = (opts[oi] === q.correct);\n answers[qid] = correct ? 'c' : 'w';\n answered++;\n\n for (i = 0; i < opts.length; i++) {\n el = byId(NS + '-o' + qid + '-' + i);\n if (opts[i] === q.correct) {\n el.className = 'mr-opt correct locked';\n } else if (i === oi) {\n el.className = 'mr-opt wrong locked';\n } else {\n el.className = 'mr-opt dimmed locked';\n }\n }\n\n byId(NS + '-exp' + qid).style.display = 'block';\n byId(NS + '-pip' + qid).className = 'mr-pip ' + (correct ? 'correct' : 'wrong');\n\n if (qid > 1) {\n var pl = gid('pl' + qid);\n if (pl) pl.className = 'mr-pip-line done';\n }\n }\n\n function showScore() {\n var c, w, s, net, pct, disp, verdicts, vi, sc;\n if (done) return;\n done = true;\n\n c = countVal('c');\n w = countVal('w');\n s = TOTAL - answered;\n net = (c * 4) - w;\n pct = Math.max(0, Math.round((net \/ MAX) * 100));\n disp = Math.min(100, Math.max(0, pct));\n\n gid('ring').style.background =\n 'conic-gradient(#4B3A6E ' + disp + '%, #E0D8EC 0%)';\n\n gid('pct').textContent = pct + '%';\n gid('net').textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n verdicts = [\n [5, 'Clean sweep \\u2014 stage-pain discordance and infertility mechanism both nailed.'],\n [4, 'Strong round \\u2014 one diagnostic-standard or mechanism point to revisit.'],\n [3, 'Solid base \\u2014 the debrief will sharpen the adenomyosis-vs-fibroid and add-back logic.'],\n [2, 'Halfway there \\u2014 review the missed cases carefully.'],\n [0, 'Endometriosis rewards close re-reading \\u2014 the stage-vs-pain discordance is the one to watch.']\n ];\n gid('verdict').textContent = verdicts[4][1];\n for (vi = 0; vi < verdicts.length; vi++) {\n if (c >= verdicts[vi][0]) {\n gid('verdict').innerHTML = verdicts[vi][1];\n break;\n }\n }\n\n gid('ct-c').textContent = '\\u2705 ' + c + ' Correct';\n gid('ct-w').textContent = '\\u274C ' + w + ' Wrong';\n gid('ct-s').textContent = '\\u23ED ' + s + ' Skipped';\n\n sc = gid('score');\n sc.style.display = 'block';\n sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n }\n\n function tryInit() {\n var sentinel = document.getElementById(NS + '-sentinel');\n var submit = document.getElementById(NS + '-submit');\n var retry = document.getElementById(NS + '-retry');\n if (!sentinel || !submit || !retry) {\n setTimeout(tryInit, 80);\n return;\n }\n submit.addEventListener('click', showScore);\n retry.addEventListener('click', function () {\n build();\n window.scrollTo(0, 0);\n });\n var bar = document.getElementById(NS + '-progress');\n if (bar && window.IntersectionObserver) {\n new IntersectionObserver(function (entries) {\n bar.className = entries[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n }, { threshold: 0 }).observe(sentinel);\n }\n build();\n }\n\n tryInit();\n\n}());\n<\/script>\n\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Endometriosis & Adenomyosis Morning Rounds · Gynaecology Series · Round 04 Endometriosis &Adenomyosis Five cases · Diagnosis, pathophysiology, infertility & long-term management · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,55],"tags":[82,93,83],"class_list":["post-37111","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-obg","tag-cms","tag-gynaecology","tag-neet-pg"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Endometriosis & Adenomyosis - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endometriosis & Adenomyosis - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Endometriosis & Adenomyosis Morning Rounds · Gynaecology Series · Round 04 Endometriosis &Adenomyosis Five cases · Diagnosis, pathophysiology, infertility & long-term management · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-26T00:23:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T00:24:21+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Endometriosis & Adenomyosis\",\"datePublished\":\"2026-06-26T00:23:46+00:00\",\"dateModified\":\"2026-06-26T00:24:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/\"},\"wordCount\":46,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"CMS\",\"Gynaecology\",\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"OBG\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/\",\"name\":\"Endometriosis & Adenomyosis - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-06-26T00:23:46+00:00\",\"dateModified\":\"2026-06-26T00:24:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/endometriosis-adenomyosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endometriosis & Adenomyosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endometriosis & Adenomyosis - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/","og_locale":"en_US","og_type":"article","og_title":"Endometriosis & Adenomyosis - atsixty","og_description":"Morning Rounds \u00b7 Endometriosis & Adenomyosis Morning Rounds · Gynaecology Series · Round 04 Endometriosis &Adenomyosis Five cases · Diagnosis, pathophysiology, infertility & long-term management · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round","og_url":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/","og_site_name":"atsixty","article_published_time":"2026-06-26T00:23:46+00:00","article_modified_time":"2026-06-26T00:24:21+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Endometriosis & Adenomyosis","datePublished":"2026-06-26T00:23:46+00:00","dateModified":"2026-06-26T00:24:21+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/"},"wordCount":46,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["CMS","Gynaecology","NEET-PG"],"articleSection":["Morning Rounds","OBG"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/","url":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/","name":"Endometriosis & Adenomyosis - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-06-26T00:23:46+00:00","dateModified":"2026-06-26T00:24:21+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/obg\/endometriosis-adenomyosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Endometriosis & Adenomyosis"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37111"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37111\/revisions"}],"predecessor-version":[{"id":37112,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37111\/revisions\/37112"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}